Skip to content
value.today

Amplifi Vascular, Inc.

🇺🇸 Prairie Village, Kansas, USABiotechnologyFounded 2023

Formerly Amplifi Medical, Inc.

Total raised
$6 M
1 round on record
Latest round
$6 M
Aug 2024
First round on record
Aug 2024
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Amplifi Vascular, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2024$6 MNo. 1$2 to $10 million

Amplifi Vascular, Inc.: Raise no. 1, Aug 2024

Investors in this round

59 investors had bought by the notice of Jun 30, 2026: 59 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $12 M offered; $6 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Sean Morris · Executive Officer, Director
  • James Schultz · Director
  • Nathaniel Hagedorn · Director
  • Steve Braun · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sean Morris, CEO/President. Source: SEC Form D and 2 amendments, newest notice filed Jun 30, 2026. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Amplifi Vascular, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2026).

    SEC Form D · Jun 2026

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jun 2026

That is all the official record says: Amplifi Vascular, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Amplifi Vascular, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 59 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Amplifi Vascular, Inc.
NameRoleNamed in
Sean MorrisExecutive officerJun 2026
James SchultzDirectorJun 2026
Nathaniel HagedornDirectorJun 2026
Sean MorrisDirectorJun 2026
Steve BraunDirectorJun 2026